MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. IRT
6. QCOM
7. ASO
8. SPY
9. EVMN
10. AAPL

Go back to MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
(NASDAQ: MTVA) Delayed: 1.63 -0.07 (4.12%)
Previous Close $1.70    52 Week High $ 
Open $1.70    52 Week Low $ 
Day High $1.79    P/E N/A 
Day Low $1.52    EPS $ 
Volume 342,913